Nirsevimab doses for 2024-2025 RSV season can be reserved with new program
February 2nd 2024Nirsevimab was approved by the FDA on July 17, 2023, ahead of the traditional RSV season, though in October, the Centers for Disease Control and Prevention (CDC) recommended it be prioritized for the highest-risk infants amid limited availability.
Quiz: Recommendations for influenza control in children from the American Academy of Pediatrics
February 1st 2024Take this quiz and test your knowledge of the American Academy of Pediatrics' recommendations for routine use of influenza vaccines, medications for the prevention and treatment of pediatric influenza.
Ibuprofen not linked to lower mortality, bronchopulmonary dysplasia risk in infants
January 30th 2024There are reports that prophylaxis with ibuprofen in the first 12 to 24 hours of life can reduce the risk of severe intraventricular hemorrhage and pulmonary hemorrhage. However, it has not been found to increase survival without neurosensory impairment at 18 months.
Paxlovid EUA revised, emergency use still authorized in pediatric patients
January 29th 2024Though revisions have been made to the emergency use authorization (EUA), the FDA stated in a press release that the EUA will continue to authorize emergency use in children aged 12 years and older who are at high risk of severe COVID-19.
Cell-based flu shots may be more cost-effective, beneficial for pediatric population
January 28th 2024A new predictive model from Taiwan suggests cell-based quadrivalent flu vaccines may better egg-based options in reducing disease burden and improving the societal costs of the flu season among children and adolescents.
Recent reports of measles in multiple states
January 25th 2024Tina Tan, MD, FAAP, FIDSA, FPIDS, tells Contemporary Pediatrics, “This is not new and demonstrates what is known, in that if vaccination rates do not stay at a level that is protective, outbreaks of vaccine preventable diseases will occur.”
Decline in cannabis use observed for students in county of Washington state
January 24th 2024In 2021, current-use prevalence of cannabis was lower among male students compared to female students for the first time. This led investigators to conclude that developing interventions that consider protective factors by sex or gender could lead to equity in cannabis reduction strategies among youth.
How could NexoBrid change the pediatric thermal burn treatment landscape?
January 24th 2024“In pediatric patients, we know that there will be increased scar tissue formation, so it is even more necessary to prevent and reduce the residual burn scars,” Stan Monstrey, former secretary general, president, European Association of Plastic Surgeons, told Contemporary Pediatrics.
Study finds buprenorphine reduces congenital malformation risk in infants
January 24th 2024A recent study revealed that infants exposed to buprenorphine during the first trimester exhibit a significantly decreased risk of developing congenital malformations associated with opioid exposure compared to infants exposed to methadone.